Literature DB >> 21304830

Botulinum toxin therapy for osteoarticular pain: an evidence-based review.

Jasvinder A Singh.   

Abstract

Botulinum (BoNT) toxin has been used for its muscle-paralyzing action in conditions such as treatment of wrinkles, cervical dystonia and blephrospasm. There is preclinical and emerging clinical evidence of another mechanism of action of BoNT, namely, an antinociceptive action. In this review, we provide an evidence-based review of clinical studies of BoNT in osteoarticular conditions, such as osteoarthritis, tennis elbow, low back pain, and hand pain. Many randomized controlled trials (RCTs) found evidence of short-term efficacy of an injection of BoNT in relief of pain, and in some cases, improvement of function and quality of life. However, more clinical trials are needed to better define the clinical use of BoNT for treatment of refractory osteoarticular pain.

Entities:  

Year:  2010        PMID: 21304830      PMCID: PMC3034142          DOI: 10.1177/1759720X09357113

Source DB:  PubMed          Journal:  Ther Adv Musculoskelet Dis        ISSN: 1759-720X            Impact factor:   5.346


  79 in total

1.  Physiotherapy or corticosteroid injection for shoulder pain?

Authors:  D A W M van der Windt; L M Bouter
Journal:  Ann Rheum Dis       Date:  2003-05       Impact factor: 19.103

Review 2.  Neurogenic aspects of inflammation.

Authors:  Hans-Georg Schaible; Angela Del Rosso; Marco Matucci-Cerinic
Journal:  Rheum Dis Clin North Am       Date:  2005-02       Impact factor: 2.670

3.  Health-related quality of life in older adults with symptomatic hip and knee osteoarthritis: a comparison with matched healthy controls.

Authors:  Fausto Salaffi; Marina Carotti; Andrea Stancati; Walter Grassi
Journal:  Aging Clin Exp Res       Date:  2005-08       Impact factor: 3.636

4.  An open label pilot investigation of the efficacy of Botulinum toxin type A [Dysport] injection in the rehabilitation of chronic anterior knee pain.

Authors:  B J Singer; P L Silbert; J W Dunne; S Song; K P Singer
Journal:  Disabil Rehabil       Date:  2006-06-15       Impact factor: 3.033

5.  A lack of antinociceptive or antiinflammatory effect of botulinum toxin A in an inflammatory human pain model.

Authors:  Thomas Sycha; Doris Samal; Boris Chizh; Stephan Lehr; Burkhard Gustorff; Peter Schnider; Eduard Auff
Journal:  Anesth Analg       Date:  2006-02       Impact factor: 5.108

Review 6.  Neuroanatomy of the pain system and of the pathways that modulate pain.

Authors:  W D Willis; K N Westlund
Journal:  J Clin Neurophysiol       Date:  1997-01       Impact factor: 2.177

Review 7.  Transcriptional and posttranslational plasticity and the generation of inflammatory pain.

Authors:  C J Woolf; M Costigan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

Review 8.  Physical therapy interventions for patients with osteoarthritis of the knee: an overview of systematic reviews.

Authors:  Gro Jamtvedt; Kristin Thuve Dahm; Anne Christie; Rikke H Moe; Espen Haavardsholm; Inger Holm; Kåre B Hagen
Journal:  Phys Ther       Date:  2007-11-06

9.  Concentration of substance P, neurokinin A, calcitonin gene-related peptide, neuropeptide Y and vasoactive intestinal polypeptide in synovial fluid from knee joints in patients suffering from rheumatoid arthritis.

Authors:  J Larsson; A Ekblom; K Henriksson; T Lundeberg; E Theodorsson
Journal:  Scand J Rheumatol       Date:  1991       Impact factor: 3.641

10.  Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.

Authors:  R Y Yuan; J J Sheu; J M Yu; W T Chen; I J Tseng; H H Chang; C J Hu
Journal:  Neurology       Date:  2009-02-25       Impact factor: 9.910

View more
  8 in total

1.  Purification and characterization of a novel subtype a3 botulinum neurotoxin.

Authors:  William H Tepp; Guangyun Lin; Eric A Johnson
Journal:  Appl Environ Microbiol       Date:  2012-02-24       Impact factor: 4.792

2.  Transient muscle paralysis degrades bone via rapid osteoclastogenesis.

Authors:  Antonios O Aliprantis; Marina Stolina; Paul J Kostenuik; Sandra L Poliachik; Sarah E Warner; Steven D Bain; Ted S Gross
Journal:  FASEB J       Date:  2011-11-28       Impact factor: 5.191

3.  Efficacy of Long-term Effect and Repeat Intraarticular Botulinum toxin in Patients with Painful Total Joint Arthroplasty: A Retrospective Study.

Authors:  Jasvinder A Singh
Journal:  Br J Med Med Res       Date:  2014-01

Review 4.  Use of botulinum toxin in musculoskeletal pain.

Authors:  Jasvinder A Singh
Journal:  F1000Res       Date:  2013-02-15

5.  The effect of intra-articular botulinum toxin A on substance P, prostaglandin E2, and tumor necrosis factor alpha in the canine osteoarthritic joint.

Authors:  Helka M Heikkilä; Anna K Hielm-Björkman; John F Innes; Outi M Laitinen-Vapaavuori
Journal:  BMC Vet Res       Date:  2017-03-21       Impact factor: 2.741

6.  Nonoperative treatment approach to knee osteoarthritis in the master athlete.

Authors:  Joel B Huleatt; Kevin J Campbell; Robert F Laprade
Journal:  Sports Health       Date:  2014-01       Impact factor: 3.843

7.  Selective inhibition of meningeal nociceptors by botulinum neurotoxin type A: therapeutic implications for migraine and other pains.

Authors:  Rami Burstein; XiChun Zhang; Dan Levy; K Roger Aoki; Mitchell F Brin
Journal:  Cephalalgia       Date:  2014-04-02       Impact factor: 6.292

8.  Beyond the muscular effects - onabotulinumtoxinA injections for pain control in chronic knee osteoarthritis: a case report.

Authors:  Gordon D Ko; Kim Isabelle Lam; Jonathan Looi; Kinga T Koprowicz; Mark Tsai; Thomas R Hein
Journal:  J Pain Res       Date:  2018-09-21       Impact factor: 3.133

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.